BACKGROUND: Elevated systemic levels of myeloperoxidase (MPO) have been associated with unfavourable clinical outcomes. In the present study, we evaluate the impact of MPO, a pro-oxidant enzyme that catalyzes the initiation of lipid peroxidation and affects nitric oxide levels, on the risk of all-cause mortality in a large population of frail octogenarians and nonagenarians living in community. METHODS: We analyzed data from the Aging and Longevity Study in the Sirente Geographic Area (ilSIRENTE Study), a prospective cohort study that collected data on all individuals aged 80 years and older living in a mountain community (n = 363). The main outcome measure was the risk of death after 4 years of follow-up. Participants were divided into three groups based on MPO tertiles: lower tertile < or = 61.5 microg/L (n = 120), intermediate tertile 61.6-140.6 microg/L (n = 120), and higher tertile > or = 140.7 microg/L (n = 123). RESULTS: A total of 150 deaths occurred during 4-years follow-up. The mean MPO level was 170.8 + or - 177.5 microg/L among those who died compared with 135.4 + or - 142.4 microg/L among survivors (p = .03). Individuals in the highest MPO tertile had higher risk of mortality (40% [60/123]) compared with those in the lower tertile (26% [39/120]). After adjusting for potential confounders, compared with participants in the lower tertile, those in the higher tertile had a hazard ratio for mortality of 1.97 (95% confidence interval: 1.02-3.80). CONCLUSION: Our results obtained from a representative sample of very old and frail elderly individuals expand the knowledge that low levels of MPO are associated with better survival.
BACKGROUND: Elevated systemic levels of myeloperoxidase (MPO) have been associated with unfavourable clinical outcomes. In the present study, we evaluate the impact of MPO, a pro-oxidant enzyme that catalyzes the initiation of lipid peroxidation and affects nitric oxide levels, on the risk of all-cause mortality in a large population of frail octogenarians and nonagenarians living in community. METHODS: We analyzed data from the Aging and Longevity Study in the Sirente Geographic Area (ilSIRENTE Study), a prospective cohort study that collected data on all individuals aged 80 years and older living in a mountain community (n = 363). The main outcome measure was the risk of death after 4 years of follow-up. Participants were divided into three groups based on MPO tertiles: lower tertile < or = 61.5 microg/L (n = 120), intermediate tertile 61.6-140.6 microg/L (n = 120), and higher tertile > or = 140.7 microg/L (n = 123). RESULTS: A total of 150 deaths occurred during 4-years follow-up. The mean MPO level was 170.8 + or - 177.5 microg/L among those who died compared with 135.4 + or - 142.4 microg/L among survivors (p = .03). Individuals in the highest MPO tertile had higher risk of mortality (40% [60/123]) compared with those in the lower tertile (26% [39/120]). After adjusting for potential confounders, compared with participants in the lower tertile, those in the higher tertile had a hazard ratio for mortality of 1.97 (95% confidence interval: 1.02-3.80). CONCLUSION: Our results obtained from a representative sample of very old and frail elderly individuals expand the knowledge that low levels of MPO are associated with better survival.
Authors: J Miquel; A Ramirez-Boscá; A Soler; A Díez; M A Carrión-Gutiérrez; J Díaz-Alperi; E Quintanilla-Ripoll; A Bernd; E Quintanilla-Almagro Journal: Mech Ageing Dev Date: 1998-01-12 Impact factor: 5.432
Authors: Lemin Zheng; Megan Settle; Gregory Brubaker; Dave Schmitt; Stanley L Hazen; Jonathan D Smith; Michael Kinter Journal: J Biol Chem Date: 2004-10-21 Impact factor: 5.157
Authors: Joseph A Vita; Marie-Luise Brennan; Noyan Gokce; Shirley A Mann; Marlene Goormastic; Mehdi H Shishehbor; Marc S Penn; John F Keaney; Stanley L Hazen Journal: Circulation Date: 2004-08-23 Impact factor: 29.690
Authors: W H Wilson Tang; Ronit Katz; Marie-Luise Brennan; Ronnier J Aviles; Russell P Tracy; Bruce M Psaty; Stanley L Hazen Journal: Am J Cardiol Date: 2009-03-13 Impact factor: 2.778
Authors: Alberto Dominguez-Rodriguez; Sima Samimi-Fard; Pedro Abreu-Gonzalez; Martin J Garcia-Gonzalez; Juan Carlos Kaski Journal: Am J Cardiol Date: 2008-03-26 Impact factor: 2.778
Authors: Marijn C Meuwese; Erik S G Stroes; Stanley L Hazen; Joram N van Miert; Jan Albert Kuivenhoven; Robert G Schaub; Nicholas J Wareham; Robert Luben; John J P Kastelein; Kay-Tee Khaw; S Matthijs Boekholdt Journal: J Am Coll Cardiol Date: 2007-06-21 Impact factor: 24.094
Authors: Carolina Nunes da Silva; Flavia Rodrigues da Silva; Lays Fernanda Nunes Dourado; Pablo Victor Mendes Dos Reis; Rummenigge Oliveira Silva; Bruna Lopes da Costa; Paula Santos Nunes; Flávio Almeida Amaral; Vera Lúcia Dos Santos; Maria Elena de Lima; Armando da Silva Cunha Júnior Journal: Toxins (Basel) Date: 2019-04-04 Impact factor: 4.546
Authors: Julia Carracedo; Rafael Ramírez-Carracedo; Irene Martínez de Toda; Carmen Vida; Matilde Alique; Mónica De la Fuente; Rafael Ramírez-Chamond Journal: Int J Mol Sci Date: 2018-05-17 Impact factor: 5.923